- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech High Growth Potential Companies
Swedish Pharmaceuticals & Biotech High Growth Potential Companies
Results
32
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
32 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | SEK 3.50 | -3.3% | -6.9% | SEK 84.9m | SEK 8.00 | PS2.3x | E130.0% | n/a | ||
INIT | SEK 7.10 | 1.4% | -22.3% | SEK 399.3m | SEK 22.50 | PB16.5x | E31.7% | n/a | ||
ACE | SEK 3.18 | 0.6% | -16.6% | SEK 305.1m | SEK 8.25 | PB2.8x | E47.2% | n/a | ||
CAMX | SEK 564.50 | 0.3% | 9.8% | SEK 33.2b | SEK 745.00 | PE124.7x | E83.1% | n/a | ||
BONEX | SEK 375.20 | 7.1% | 99.4% | SEK 24.7b | SEK 402.33 | PE272.6x | E72.2% | n/a | ||
SPAGO | SEK 0.18 | 3.5% | -43.2% | SEK 61.3m | SEK 0.80 | PS8.8x | E78.0% | n/a | ||
KLAR | SEK 0.31 | -10.6% | -25.1% | SEK 45.3m | SEK 0.70 | PB3.5x | E89.7% | n/a | ||
XBRANE | SEK 0.17 | -2.9% | -98.0% | SEK 260.0m | SEK 0.45 | PS1.3x | E130.2% | n/a | ||
EGTX | SEK 7.28 | 9.0% | 20.3% | SEK 2.6b | SEK 11.00 | PS38.5x | E97.3% | n/a | ||
BIOA B | SEK 171.60 | -4.8% | -35.6% | SEK 15.2b | SEK 322.00 | PS90.7x | E62.5% | 0% | ||
XSPRAY | SEK 43.85 | -3.2% | 19.8% | SEK 1.5b | SEK 76.00 | PB2.5x | E134.8% | n/a | ||
LPGO | SEK 0.18 | -7.6% | -57.9% | SEK 26.6m | SEK 0.90 | PS3x | E139.5% | n/a | ||
CLBIO | SEK 8.32 | 8.6% | -41.4% | SEK 178.8m | SEK 23.00 | PS7.6x | E114.7% | n/a | ||
KAN | SEK 1.12 | 2.9% | -77.6% | SEK 136.0m | SEK 3.10 | PB1.9x | E48.3% | n/a | ||
SENZA | SEK 7.00 | 0.7% | -1.4% | SEK 206.5m | SEK 16.00 | PS3.5x | E120.0% | n/a | ||
DVYSR | SEK 117.00 | -4.1% | 46.3% | SEK 1.9b | SEK 158.82 | PS9.8x | E118.8% | n/a | ||
BINV | SEK 38.80 | -6.5% | 118.7% | SEK 2.6b | SEK 90.00 | PS66.1x | E108.6% | n/a | ||
RLS | SEK 0.45 | -0.2% | -84.2% | SEK 35.6m | SEK 7.00 | PS33.1x | E92.8% | n/a | ||
IRLAB A | SEK 11.25 | -6.6% | 79.7% | SEK 583.5m | SEK 56.07 | PS11.5x | E23.5% | n/a | ||
ALIF B | SEK 134.00 | -5.0% | 22.0% | SEK 16.3b | SEK 165.50 | PE139.6x | E52.0% | 0.4% | ||
VITR | SEK 212.00 | -2.0% | 13.1% | SEK 28.7b | SEK 273.33 | PS8.1x | E96.8% | 0.5% | ||
SYNACT | SEK 9.65 | -11.6% | 24.4% | SEK 398.5m | SEK 16.00 | PB2.4x | E99.2% | n/a | ||
PROB | SEK 348.00 | 0.3% | 70.6% | SEK 4.0b | n/a | PE364.3x | E62.0% | 0.4% | ||
BIOG B | SEK 109.60 | 1.5% | 10.3% | SEK 11.1b | SEK 150.00 | PE32.9x | E16.6% | 6.3% |